Advanced Health Intelligence Ltd (ASX: AHI.AX) Stock Competitors & Peer Comparison

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, XRO.AX has a market cap of 15B. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while XRO.AX trades at A$88.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas XRO.AX's P/E ratio is 104.15. In terms of profitability, AHI.AX's ROE is -2.19%, compared to XRO.AX's ROE of +0.04%. Regarding short-term risk, AHI.AX is more volatile compared to XRO.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check XRO.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, WTC.AX has a market cap of 14.6B. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while WTC.AX trades at A$44.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas WTC.AX's P/E ratio is 38.80. In terms of profitability, AHI.AX's ROE is -2.19%, compared to WTC.AX's ROE of +0.09%. Regarding short-term risk, AHI.AX is more volatile compared to WTC.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check WTC.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, TNE.AX has a market cap of 10.8B. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while TNE.AX trades at A$33.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas TNE.AX's P/E ratio is 77.82. In terms of profitability, AHI.AX's ROE is -2.19%, compared to TNE.AX's ROE of +0.32%. Regarding short-term risk, AHI.AX is more volatile compared to TNE.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check TNE.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, 360.AX has a market cap of 5.1B. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while 360.AX trades at A$20.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas 360.AX's P/E ratio is 19.54. In terms of profitability, AHI.AX's ROE is -2.19%, compared to 360.AX's ROE of +0.28%. Regarding short-term risk, AHI.AX is more volatile compared to 360.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check 360.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, BVS.AX has a market cap of 1.4B. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while BVS.AX trades at A$3.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas BVS.AX's P/E ratio is 36.19. In terms of profitability, AHI.AX's ROE is -2.19%, compared to BVS.AX's ROE of +1.07%. Regarding short-term risk, AHI.AX is more volatile compared to BVS.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check BVS.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, PXA.AX has a market cap of 1.4B. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while PXA.AX trades at A$8.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas PXA.AX's P/E ratio is -61.90. In terms of profitability, AHI.AX's ROE is -2.19%, compared to PXA.AX's ROE of -0.05%. Regarding short-term risk, AHI.AX is more volatile compared to PXA.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check PXA.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, IRE.AX has a market cap of 1.2B. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while IRE.AX trades at A$6.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas IRE.AX's P/E ratio is 14.67. In terms of profitability, AHI.AX's ROE is -2.19%, compared to IRE.AX's ROE of +0.22%. Regarding short-term risk, AHI.AX is more volatile compared to IRE.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check IRE.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, RUL.AX has a market cap of 1.1B. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while RUL.AX trades at A$4.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas RUL.AX's P/E ratio is 166.33. In terms of profitability, AHI.AX's ROE is -2.19%, compared to RUL.AX's ROE of +0.64%. Regarding short-term risk, AHI.AX is more volatile compared to RUL.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check RUL.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, SDR.AX has a market cap of 1.1B. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while SDR.AX trades at A$3.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas SDR.AX's P/E ratio is -70.91. In terms of profitability, AHI.AX's ROE is -2.19%, compared to SDR.AX's ROE of -0.26%. Regarding short-term risk, AHI.AX is less volatile compared to SDR.AX. This indicates lower risk in terms of short-term price fluctuations for AHI.AX.Check SDR.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, C79.AX has a market cap of 852.9M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while C79.AX trades at A$7.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas C79.AX's P/E ratio is -171.67. In terms of profitability, AHI.AX's ROE is -2.19%, compared to C79.AX's ROE of +0.01%. Regarding short-term risk, AHI.AX is more volatile compared to C79.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check C79.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, FCL.AX has a market cap of 776.3M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while FCL.AX trades at A$2.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas FCL.AX's P/E ratio is 151.11. In terms of profitability, AHI.AX's ROE is -2.19%, compared to FCL.AX's ROE of -0.00%. Regarding short-term risk, AHI.AX is more volatile compared to FCL.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check FCL.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, OCL.AX has a market cap of 720M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while OCL.AX trades at A$7.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas OCL.AX's P/E ratio is 20.19. In terms of profitability, AHI.AX's ROE is -2.19%, compared to OCL.AX's ROE of +0.26%. Regarding short-term risk, AHI.AX is more volatile compared to OCL.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check OCL.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, HSN.AX has a market cap of 678.9M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while HSN.AX trades at A$3.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas HSN.AX's P/E ratio is 22.23. In terms of profitability, AHI.AX's ROE is -2.19%, compared to HSN.AX's ROE of +0.12%. Regarding short-term risk, AHI.AX is more volatile compared to HSN.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check HSN.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, NXL.AX has a market cap of 648.7M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while NXL.AX trades at A$2.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas NXL.AX's P/E ratio is 25.15. In terms of profitability, AHI.AX's ROE is -2.19%, compared to NXL.AX's ROE of +0.04%. Regarding short-term risk, AHI.AX is less volatile compared to NXL.AX. This indicates lower risk in terms of short-term price fluctuations for AHI.AX.Check NXL.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, IFM.AX has a market cap of 640.5M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while IFM.AX trades at A$1.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas IFM.AX's P/E ratio is 42.38. In terms of profitability, AHI.AX's ROE is -2.19%, compared to IFM.AX's ROE of +0.12%. Regarding short-term risk, AHI.AX is more volatile compared to IFM.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check IFM.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, VGL.AX has a market cap of 567.1M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while VGL.AX trades at A$2.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas VGL.AX's P/E ratio is 601.52. In terms of profitability, AHI.AX's ROE is -2.19%, compared to VGL.AX's ROE of +0.01%. Regarding short-term risk, AHI.AX is more volatile compared to VGL.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check VGL.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, NTO.AX has a market cap of 559.5M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while NTO.AX trades at A$2.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas NTO.AX's P/E ratio is -9.95. In terms of profitability, AHI.AX's ROE is -2.19%, compared to NTO.AX's ROE of -0.37%. Regarding short-term risk, AHI.AX is more volatile compared to NTO.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check NTO.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, EOL.AX has a market cap of 556.8M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while EOL.AX trades at A$17.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas EOL.AX's P/E ratio is 78.44. In terms of profitability, AHI.AX's ROE is -2.19%, compared to EOL.AX's ROE of +0.12%. Regarding short-term risk, AHI.AX is more volatile compared to EOL.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check EOL.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, ELO.AX has a market cap of 483.4M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while ELO.AX trades at A$4.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas ELO.AX's P/E ratio is -5.68. In terms of profitability, AHI.AX's ROE is -2.19%, compared to ELO.AX's ROE of -0.59%. Regarding short-term risk, AHI.AX is more volatile compared to ELO.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check ELO.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, DSE.AX has a market cap of 418.2M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while DSE.AX trades at A$5.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas DSE.AX's P/E ratio is 588.00. In terms of profitability, AHI.AX's ROE is -2.19%, compared to DSE.AX's ROE of +0.03%. Regarding short-term risk, AHI.AX is more volatile compared to DSE.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check DSE.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, PPS.AX has a market cap of 355.9M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while PPS.AX trades at A$0.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas PPS.AX's P/E ratio is 15.53. In terms of profitability, AHI.AX's ROE is -2.19%, compared to PPS.AX's ROE of +0.15%. Regarding short-term risk, AHI.AX is more volatile compared to PPS.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check PPS.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, SPZ.AX has a market cap of 332.1M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while SPZ.AX trades at A$0.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas SPZ.AX's P/E ratio is 33.33. In terms of profitability, AHI.AX's ROE is -2.19%, compared to SPZ.AX's ROE of +0.07%. Regarding short-term risk, AHI.AX is more volatile compared to SPZ.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check SPZ.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, BET.AX has a market cap of 240.9M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while BET.AX trades at A$0.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas BET.AX's P/E ratio is -10.32. In terms of profitability, AHI.AX's ROE is -2.19%, compared to BET.AX's ROE of -0.13%. Regarding short-term risk, AHI.AX is more volatile compared to BET.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check BET.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, AND.AX has a market cap of 235M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while AND.AX trades at A$2.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas AND.AX's P/E ratio is -249.00. In terms of profitability, AHI.AX's ROE is -2.19%, compared to AND.AX's ROE of -0.02%. Regarding short-term risk, AHI.AX is more volatile compared to AND.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check AND.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, SYM.AX has a market cap of 226.5M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while SYM.AX trades at A$2.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas SYM.AX's P/E ratio is 131.50. In terms of profitability, AHI.AX's ROE is -2.19%, compared to SYM.AX's ROE of +0.01%. Regarding short-term risk, AHI.AX is more volatile compared to SYM.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check SYM.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, RDY.AX has a market cap of 193.4M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while RDY.AX trades at A$1.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas RDY.AX's P/E ratio is -1.46. In terms of profitability, AHI.AX's ROE is -2.19%, compared to RDY.AX's ROE of +0.01%. Regarding short-term risk, AHI.AX is more volatile compared to RDY.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check RDY.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, BTH.AX has a market cap of 176.7M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while BTH.AX trades at A$0.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas BTH.AX's P/E ratio is -2.39. In terms of profitability, AHI.AX's ROE is -2.19%, compared to BTH.AX's ROE of -0.06%. Regarding short-term risk, AHI.AX is more volatile compared to BTH.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check BTH.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, SKO.AX has a market cap of 156.1M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while SKO.AX trades at A$1.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas SKO.AX's P/E ratio is -10.16. In terms of profitability, AHI.AX's ROE is -2.19%, compared to SKO.AX's ROE of -0.19%. Regarding short-term risk, AHI.AX is more volatile compared to SKO.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check SKO.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, BB1.AX has a market cap of 133.3M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while BB1.AX trades at A$0.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas BB1.AX's P/E ratio is -14.50. In terms of profitability, AHI.AX's ROE is -2.19%, compared to BB1.AX's ROE of N/A. Regarding short-term risk, AHI.AX is more volatile compared to BB1.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check BB1.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, DAI.AX has a market cap of 132.1M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while DAI.AX trades at A$0.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas DAI.AX's P/E ratio is 1.31. In terms of profitability, AHI.AX's ROE is -2.19%, compared to DAI.AX's ROE of -7.25%. Regarding short-term risk, AHI.AX is more volatile compared to DAI.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check DAI.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, EVS.AX has a market cap of 130.7M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while EVS.AX trades at A$0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas EVS.AX's P/E ratio is -2.97. In terms of profitability, AHI.AX's ROE is -2.19%, compared to EVS.AX's ROE of -0.32%. Regarding short-term risk, AHI.AX is more volatile compared to EVS.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check EVS.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, HPG.AX has a market cap of 122.9M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while HPG.AX trades at A$0.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas HPG.AX's P/E ratio is 23.32. In terms of profitability, AHI.AX's ROE is -2.19%, compared to HPG.AX's ROE of +0.29%. Regarding short-term risk, AHI.AX is more volatile compared to HPG.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check HPG.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, LME.AX has a market cap of 116.6M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while LME.AX trades at A$0.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas LME.AX's P/E ratio is -6.00. In terms of profitability, AHI.AX's ROE is -2.19%, compared to LME.AX's ROE of -1.04%. Regarding short-term risk, AHI.AX is more volatile compared to LME.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check LME.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, MSL.AX has a market cap of 108.9M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while MSL.AX trades at A$0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas MSL.AX's P/E ratio is -49.17. In terms of profitability, AHI.AX's ROE is -2.19%, compared to MSL.AX's ROE of +0.04%. Regarding short-term risk, AHI.AX is more volatile compared to MSL.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check MSL.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, PTG.AX has a market cap of 90.2M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while PTG.AX trades at A$0.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas PTG.AX's P/E ratio is -29.75. In terms of profitability, AHI.AX's ROE is -2.19%, compared to PTG.AX's ROE of -0.07%. Regarding short-term risk, AHI.AX is more volatile compared to PTG.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check PTG.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, YOJ.AX has a market cap of 88.5M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while YOJ.AX trades at A$0.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas YOJ.AX's P/E ratio is -11.24. In terms of profitability, AHI.AX's ROE is -2.19%, compared to YOJ.AX's ROE of -1.05%. Regarding short-term risk, AHI.AX is more volatile compared to YOJ.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check YOJ.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, IHR.AX has a market cap of 81.4M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while IHR.AX trades at A$0.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas IHR.AX's P/E ratio is -11.75. In terms of profitability, AHI.AX's ROE is -2.19%, compared to IHR.AX's ROE of -1.39%. Regarding short-term risk, AHI.AX is more volatile compared to IHR.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check IHR.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, WSP.AX has a market cap of 76.4M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while WSP.AX trades at A$0.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas WSP.AX's P/E ratio is -5.50. In terms of profitability, AHI.AX's ROE is -2.19%, compared to WSP.AX's ROE of -0.65%. Regarding short-term risk, AHI.AX is more volatile compared to WSP.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check WSP.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, ESK.AX has a market cap of 75M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while ESK.AX trades at A$0.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas ESK.AX's P/E ratio is -11.37. In terms of profitability, AHI.AX's ROE is -2.19%, compared to ESK.AX's ROE of -0.18%. Regarding short-term risk, AHI.AX is more volatile compared to ESK.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check ESK.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, NVU.AX has a market cap of 70.7M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while NVU.AX trades at A$0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas NVU.AX's P/E ratio is -6.35. In terms of profitability, AHI.AX's ROE is -2.19%, compared to NVU.AX's ROE of -0.76%. Regarding short-term risk, AHI.AX is more volatile compared to NVU.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check NVU.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, VNL.AX has a market cap of 68.2M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while VNL.AX trades at A$0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas VNL.AX's P/E ratio is -4.60. In terms of profitability, AHI.AX's ROE is -2.19%, compared to VNL.AX's ROE of -0.68%. Regarding short-term risk, AHI.AX is more volatile compared to VNL.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check VNL.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, DTC.AX has a market cap of 61.3M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while DTC.AX trades at A$0.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas DTC.AX's P/E ratio is -1.19. In terms of profitability, AHI.AX's ROE is -2.19%, compared to DTC.AX's ROE of -0.77%. Regarding short-term risk, AHI.AX is more volatile compared to DTC.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check DTC.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, IOD.AX has a market cap of 60.3M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while IOD.AX trades at A$0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas IOD.AX's P/E ratio is -23.06. In terms of profitability, AHI.AX's ROE is -2.19%, compared to IOD.AX's ROE of +4.30%. Regarding short-term risk, AHI.AX is more volatile compared to IOD.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check IOD.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, SKK.AX has a market cap of 56.2M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while SKK.AX trades at A$0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas SKK.AX's P/E ratio is N/A. In terms of profitability, AHI.AX's ROE is -2.19%, compared to SKK.AX's ROE of -0.09%. Regarding short-term risk, AHI.AX is more volatile compared to SKK.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check SKK.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, UBN.AX has a market cap of 52.9M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while UBN.AX trades at A$0.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas UBN.AX's P/E ratio is -20.43. In terms of profitability, AHI.AX's ROE is -2.19%, compared to UBN.AX's ROE of -0.17%. Regarding short-term risk, AHI.AX is more volatile compared to UBN.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check UBN.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, IRI.AX has a market cap of 52.4M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while IRI.AX trades at A$0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas IRI.AX's P/E ratio is -0.35. In terms of profitability, AHI.AX's ROE is -2.19%, compared to IRI.AX's ROE of +0.07%. Regarding short-term risk, AHI.AX is more volatile compared to IRI.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check IRI.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, VR1.AX has a market cap of 49.6M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while VR1.AX trades at A$0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas VR1.AX's P/E ratio is -3.98. In terms of profitability, AHI.AX's ROE is -2.19%, compared to VR1.AX's ROE of -0.60%. Regarding short-term risk, AHI.AX is more volatile compared to VR1.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check VR1.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, RKN.AX has a market cap of 48.7M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while RKN.AX trades at A$0.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas RKN.AX's P/E ratio is 6.69. In terms of profitability, AHI.AX's ROE is -2.19%, compared to RKN.AX's ROE of +0.27%. Regarding short-term risk, AHI.AX is more volatile compared to RKN.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check RKN.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, ROC.AX has a market cap of 46.6M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while ROC.AX trades at A$0.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas ROC.AX's P/E ratio is -5.75. In terms of profitability, AHI.AX's ROE is -2.19%, compared to ROC.AX's ROE of -8.70%. Regarding short-term risk, AHI.AX is more volatile compared to ROC.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check ROC.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, CCG.AX has a market cap of 46M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while CCG.AX trades at A$0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas CCG.AX's P/E ratio is 64.62. In terms of profitability, AHI.AX's ROE is -2.19%, compared to CCG.AX's ROE of +0.02%. Regarding short-term risk, AHI.AX is more volatile compared to CCG.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check CCG.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, IOV.AX has a market cap of 39.3M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while IOV.AX trades at A$0.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas IOV.AX's P/E ratio is -5.50. In terms of profitability, AHI.AX's ROE is -2.19%, compared to IOV.AX's ROE of +11.76%. Regarding short-term risk, AHI.AX is more volatile compared to IOV.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check IOV.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, K2F.AX has a market cap of 37.4M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while K2F.AX trades at A$0.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas K2F.AX's P/E ratio is -6.23. In terms of profitability, AHI.AX's ROE is -2.19%, compared to K2F.AX's ROE of -0.46%. Regarding short-term risk, AHI.AX is more volatile compared to K2F.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check K2F.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, ADA.AX has a market cap of 36.1M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while ADA.AX trades at A$0.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas ADA.AX's P/E ratio is -5.28. In terms of profitability, AHI.AX's ROE is -2.19%, compared to ADA.AX's ROE of -0.41%. Regarding short-term risk, AHI.AX is more volatile compared to ADA.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check ADA.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, JAN.AX has a market cap of 30.1M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while JAN.AX trades at A$0.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas JAN.AX's P/E ratio is -2.76. In terms of profitability, AHI.AX's ROE is -2.19%, compared to JAN.AX's ROE of -0.55%. Regarding short-term risk, AHI.AX is more volatile compared to JAN.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check JAN.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, VIG.AX has a market cap of 25.6M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while VIG.AX trades at A$0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas VIG.AX's P/E ratio is -341.67. In terms of profitability, AHI.AX's ROE is -2.19%, compared to VIG.AX's ROE of -0.03%. Regarding short-term risk, AHI.AX is less volatile compared to VIG.AX. This indicates lower risk in terms of short-term price fluctuations for AHI.AX.Check VIG.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, JXT.AX has a market cap of 25.1M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while JXT.AX trades at A$0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas JXT.AX's P/E ratio is -2.45. In terms of profitability, AHI.AX's ROE is -2.19%, compared to JXT.AX's ROE of -5.81%. Regarding short-term risk, AHI.AX is more volatile compared to JXT.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check JXT.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, 3DP.AX has a market cap of 23.7M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while 3DP.AX trades at A$0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas 3DP.AX's P/E ratio is -0.11. In terms of profitability, AHI.AX's ROE is -2.19%, compared to 3DP.AX's ROE of +1.90%. Regarding short-term risk, AHI.AX is more volatile compared to 3DP.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check 3DP.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, DUB.AX has a market cap of 21.7M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while DUB.AX trades at A$0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas DUB.AX's P/E ratio is -0.82. In terms of profitability, AHI.AX's ROE is -2.19%, compared to DUB.AX's ROE of -2.03%. Regarding short-term risk, AHI.AX is more volatile compared to DUB.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check DUB.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, TAL.AX has a market cap of 21.6M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while TAL.AX trades at A$0.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas TAL.AX's P/E ratio is -6.30. In terms of profitability, AHI.AX's ROE is -2.19%, compared to TAL.AX's ROE of -0.28%. Regarding short-term risk, AHI.AX is more volatile compared to TAL.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check TAL.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, GTI.AX has a market cap of 21.4M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while GTI.AX trades at A$0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas GTI.AX's P/E ratio is -1.14. In terms of profitability, AHI.AX's ROE is -2.19%, compared to GTI.AX's ROE of -1.24%. Regarding short-term risk, AHI.AX is more volatile compared to GTI.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check GTI.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, HTG.AX has a market cap of 21.4M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while HTG.AX trades at A$0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas HTG.AX's P/E ratio is -1.33. In terms of profitability, AHI.AX's ROE is -2.19%, compared to HTG.AX's ROE of +0.65%. Regarding short-term risk, AHI.AX is more volatile compared to HTG.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check HTG.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, LVH.AX has a market cap of 19.8M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while LVH.AX trades at A$0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas LVH.AX's P/E ratio is -1.43. In terms of profitability, AHI.AX's ROE is -2.19%, compared to LVH.AX's ROE of -1.55%. Regarding short-term risk, AHI.AX is more volatile compared to LVH.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check LVH.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, ICE.AX has a market cap of 19.7M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while ICE.AX trades at A$0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas ICE.AX's P/E ratio is -4.66. In terms of profitability, AHI.AX's ROE is -2.19%, compared to ICE.AX's ROE of -1.53%. Regarding short-term risk, AHI.AX is more volatile compared to ICE.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check ICE.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, SCL.AX has a market cap of 18M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while SCL.AX trades at A$0.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas SCL.AX's P/E ratio is -16.00. In terms of profitability, AHI.AX's ROE is -2.19%, compared to SCL.AX's ROE of -1.50%. Regarding short-term risk, AHI.AX is more volatile compared to SCL.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check SCL.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, CXZ.AX has a market cap of 16.9M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while CXZ.AX trades at A$0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas CXZ.AX's P/E ratio is 6.00. In terms of profitability, AHI.AX's ROE is -2.19%, compared to CXZ.AX's ROE of +0.29%. Regarding short-term risk, AHI.AX is more volatile compared to CXZ.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check CXZ.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, LNU.AX has a market cap of 16.1M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while LNU.AX trades at A$0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas LNU.AX's P/E ratio is -0.20. In terms of profitability, AHI.AX's ROE is -2.19%, compared to LNU.AX's ROE of +3.01%. Regarding short-term risk, AHI.AX is more volatile compared to LNU.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check LNU.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, ATV.AX has a market cap of 16M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while ATV.AX trades at A$0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas ATV.AX's P/E ratio is -0.39. In terms of profitability, AHI.AX's ROE is -2.19%, compared to ATV.AX's ROE of -1.27%. Regarding short-term risk, AHI.AX is more volatile compared to ATV.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check ATV.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, NS1.AX has a market cap of 15.9M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while NS1.AX trades at A$0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas NS1.AX's P/E ratio is -0.98. In terms of profitability, AHI.AX's ROE is -2.19%, compared to NS1.AX's ROE of N/A. Regarding short-term risk, AHI.AX is less volatile compared to NS1.AX. This indicates lower risk in terms of short-term price fluctuations for AHI.AX.Check NS1.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, DWG.AX has a market cap of 15.5M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while DWG.AX trades at A$0.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas DWG.AX's P/E ratio is -26.60. In terms of profitability, AHI.AX's ROE is -2.19%, compared to DWG.AX's ROE of -4.33%. Regarding short-term risk, AHI.AX is more volatile compared to DWG.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check DWG.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, XF1.AX has a market cap of 15M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while XF1.AX trades at A$0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas XF1.AX's P/E ratio is -6.48. In terms of profitability, AHI.AX's ROE is -2.19%, compared to XF1.AX's ROE of +0.46%. Regarding short-term risk, AHI.AX is more volatile compared to XF1.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check XF1.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, 1CG.AX has a market cap of 14.4M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while 1CG.AX trades at A$0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas 1CG.AX's P/E ratio is -4.40. In terms of profitability, AHI.AX's ROE is -2.19%, compared to 1CG.AX's ROE of -0.03%. Regarding short-term risk, AHI.AX is more volatile compared to 1CG.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check 1CG.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, CF1.AX has a market cap of 13.9M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while CF1.AX trades at A$0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas CF1.AX's P/E ratio is -5.11. In terms of profitability, AHI.AX's ROE is -2.19%, compared to CF1.AX's ROE of -0.62%. Regarding short-term risk, AHI.AX is more volatile compared to CF1.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check CF1.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, LOC.AX has a market cap of 13.4M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while LOC.AX trades at A$0.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas LOC.AX's P/E ratio is -5.60. In terms of profitability, AHI.AX's ROE is -2.19%, compared to LOC.AX's ROE of -1.73%. Regarding short-term risk, AHI.AX is more volatile compared to LOC.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check LOC.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, RLG.AX has a market cap of 11.6M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while RLG.AX trades at A$0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas RLG.AX's P/E ratio is -9.09. In terms of profitability, AHI.AX's ROE is -2.19%, compared to RLG.AX's ROE of -0.80%. Regarding short-term risk, AHI.AX is less volatile compared to RLG.AX. This indicates lower risk in terms of short-term price fluctuations for AHI.AX.Check RLG.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, NVQ.AX has a market cap of 11.1M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while NVQ.AX trades at A$0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas NVQ.AX's P/E ratio is -3.90. In terms of profitability, AHI.AX's ROE is -2.19%, compared to NVQ.AX's ROE of +3.27%. Regarding short-term risk, AHI.AX is more volatile compared to NVQ.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check NVQ.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, FLX.AX has a market cap of 11.1M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while FLX.AX trades at A$0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas FLX.AX's P/E ratio is -1.99. In terms of profitability, AHI.AX's ROE is -2.19%, compared to FLX.AX's ROE of -1.52%. Regarding short-term risk, AHI.AX is more volatile compared to FLX.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check FLX.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, OLL.AX has a market cap of 10.9M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while OLL.AX trades at A$0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas OLL.AX's P/E ratio is -1.71. In terms of profitability, AHI.AX's ROE is -2.19%, compared to OLL.AX's ROE of +4.98%. Regarding short-term risk, AHI.AX is more volatile compared to OLL.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check OLL.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, Z2U.AX has a market cap of 10.3M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while Z2U.AX trades at A$0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas Z2U.AX's P/E ratio is -5.10. In terms of profitability, AHI.AX's ROE is -2.19%, compared to Z2U.AX's ROE of -1.73%. Regarding short-term risk, AHI.AX is more volatile compared to Z2U.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check Z2U.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, UNT.AX has a market cap of 9.1M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while UNT.AX trades at A$0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas UNT.AX's P/E ratio is -2.55. In terms of profitability, AHI.AX's ROE is -2.19%, compared to UNT.AX's ROE of -0.44%. Regarding short-term risk, AHI.AX is more volatile compared to UNT.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check UNT.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, NOR.AX has a market cap of 8.7M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while NOR.AX trades at A$0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas NOR.AX's P/E ratio is -4.55. In terms of profitability, AHI.AX's ROE is -2.19%, compared to NOR.AX's ROE of +1.09%. Regarding short-term risk, AHI.AX is more volatile compared to NOR.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check NOR.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, RCL.AX has a market cap of 8.6M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while RCL.AX trades at A$0.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas RCL.AX's P/E ratio is 2.75. In terms of profitability, AHI.AX's ROE is -2.19%, compared to RCL.AX's ROE of -0.20%. Regarding short-term risk, AHI.AX is more volatile compared to RCL.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check RCL.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, CAG.AX has a market cap of 8.5M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while CAG.AX trades at A$0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas CAG.AX's P/E ratio is -9.00. In terms of profitability, AHI.AX's ROE is -2.19%, compared to CAG.AX's ROE of -0.26%. Regarding short-term risk, AHI.AX is more volatile compared to CAG.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check CAG.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, 8CO.AX has a market cap of 8.3M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while 8CO.AX trades at A$0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas 8CO.AX's P/E ratio is -9.49. In terms of profitability, AHI.AX's ROE is -2.19%, compared to 8CO.AX's ROE of -0.11%. Regarding short-term risk, AHI.AX is more volatile compared to 8CO.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check 8CO.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, MRI.AX has a market cap of 8.2M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while MRI.AX trades at A$0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas MRI.AX's P/E ratio is -2.52. In terms of profitability, AHI.AX's ROE is -2.19%, compared to MRI.AX's ROE of +0.47%. Regarding short-term risk, AHI.AX is more volatile compared to MRI.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check MRI.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, OOK.AX has a market cap of 8.2M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while OOK.AX trades at A$0.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas OOK.AX's P/E ratio is -6.00. In terms of profitability, AHI.AX's ROE is -2.19%, compared to OOK.AX's ROE of -0.27%. Regarding short-term risk, AHI.AX is more volatile compared to OOK.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check OOK.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, KNM.AX has a market cap of 7.2M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while KNM.AX trades at A$0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas KNM.AX's P/E ratio is -5.56. In terms of profitability, AHI.AX's ROE is -2.19%, compared to KNM.AX's ROE of -0.60%. Regarding short-term risk, AHI.AX is more volatile compared to KNM.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check KNM.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, 1TT.AX has a market cap of 7.1M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while 1TT.AX trades at A$0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas 1TT.AX's P/E ratio is -0.56. In terms of profitability, AHI.AX's ROE is -2.19%, compared to 1TT.AX's ROE of -5.63%. Regarding short-term risk, AHI.AX is more volatile compared to 1TT.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check 1TT.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, LVT.AX has a market cap of 7.1M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while LVT.AX trades at A$0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas LVT.AX's P/E ratio is -0.10. In terms of profitability, AHI.AX's ROE is -2.19%, compared to LVT.AX's ROE of -0.69%. Regarding short-term risk, AHI.AX is more volatile compared to LVT.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check LVT.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, SYT.AX has a market cap of 5.7M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while SYT.AX trades at A$0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas SYT.AX's P/E ratio is N/A. In terms of profitability, AHI.AX's ROE is -2.19%, compared to SYT.AX's ROE of +0.39%. Regarding short-term risk, AHI.AX is more volatile compared to SYT.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check SYT.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, KNO.AX has a market cap of 5.4M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while KNO.AX trades at A$0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas KNO.AX's P/E ratio is -34.25. In terms of profitability, AHI.AX's ROE is -2.19%, compared to KNO.AX's ROE of -0.53%. Regarding short-term risk, AHI.AX is more volatile compared to KNO.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check KNO.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, SIS.AX has a market cap of 5.1M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while SIS.AX trades at A$0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas SIS.AX's P/E ratio is -2.29. In terms of profitability, AHI.AX's ROE is -2.19%, compared to SIS.AX's ROE of +2.27%. Regarding short-term risk, AHI.AX is more volatile compared to SIS.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check SIS.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, TYM.AX has a market cap of 5M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while TYM.AX trades at A$0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas TYM.AX's P/E ratio is 0.40. In terms of profitability, AHI.AX's ROE is -2.19%, compared to TYM.AX's ROE of -1.39%. Regarding short-term risk, AHI.AX is more volatile compared to TYM.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check TYM.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, AER.AX has a market cap of 4.7M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while AER.AX trades at A$0.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas AER.AX's P/E ratio is -13.16. In terms of profitability, AHI.AX's ROE is -2.19%, compared to AER.AX's ROE of -0.35%. Regarding short-term risk, AHI.AX is more volatile compared to AER.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check AER.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, WOO.AX has a market cap of 4.6M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while WOO.AX trades at A$0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas WOO.AX's P/E ratio is -2.00. In terms of profitability, AHI.AX's ROE is -2.19%, compared to WOO.AX's ROE of -0.89%. Regarding short-term risk, AHI.AX is more volatile compared to WOO.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check WOO.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, PRO.AX has a market cap of 4.3M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while PRO.AX trades at A$0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas PRO.AX's P/E ratio is -0.53. In terms of profitability, AHI.AX's ROE is -2.19%, compared to PRO.AX's ROE of +7.84%. Regarding short-term risk, AHI.AX is more volatile compared to PRO.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check PRO.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, BGE.AX has a market cap of 3.8M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while BGE.AX trades at A$0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas BGE.AX's P/E ratio is -3.17. In terms of profitability, AHI.AX's ROE is -2.19%, compared to BGE.AX's ROE of -0.92%. Regarding short-term risk, AHI.AX is more volatile compared to BGE.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check BGE.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, OPA.AX has a market cap of 3.8M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while OPA.AX trades at A$0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas OPA.AX's P/E ratio is -0.30. In terms of profitability, AHI.AX's ROE is -2.19%, compared to OPA.AX's ROE of N/A. Regarding short-term risk, AHI.AX is more volatile compared to OPA.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check OPA.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, ID8.AX has a market cap of 3.7M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while ID8.AX trades at A$0.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas ID8.AX's P/E ratio is -152.38. In terms of profitability, AHI.AX's ROE is -2.19%, compared to ID8.AX's ROE of -5.25%. Regarding short-term risk, AHI.AX is less volatile compared to ID8.AX. This indicates lower risk in terms of short-term price fluctuations for AHI.AX.Check ID8.AX's competition here

Advanced Health Intelligence Ltd (ASX: AHI.AX) plays a significant role within the Technology sector. Its performance on the ASX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AHI.AX stands at 24.8M. In comparison, DCL.AX has a market cap of 2.6M. Regarding current trading prices, AHI.AX is priced at A$0.09 on the ASX, while DCL.AX trades at A$0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AHI.AX currently has a P/E ratio of -4.44, whereas DCL.AX's P/E ratio is -0.83. In terms of profitability, AHI.AX's ROE is -2.19%, compared to DCL.AX's ROE of +2.22%. Regarding short-term risk, AHI.AX is more volatile compared to DCL.AX. This indicates higher risk in terms of short-term price fluctuations for AHI.AX.Check DCL.AX's competition here